QNTM (quantumbiopharma.com) Bozor qiymatining balans qiymatiga nisbati

Quantum BioPharma Ltd. (QNTM) kompaniyasining rasmiy ramzlari

Quantum BioPharma Ltd (QNTM) aksiyalari uchun bozor tendentsiyasi 2.11 darajasidagi dinamikani aks ettiradi. Yuqori sinov xarajatlari va patent himoyasi bozorga kirishda jiddiy to'siqlar yaratadi, FDA esa yangi dorilarni ishga tushirishni qat'iy ravishda nazorat qiladi. Quantum BioPharma Ltd biotexnologiya sohasidagi obro'sini tiklamoqda, tabiiy yallig'lanishga qarshi dorilarni ishlab chiqish uchun Isroil va Kanadadagi imkoniyatlardan foydalanmoqda.

QNTM Quantum BioPharma Corp: Balans qiymatiga nisbatan bozor qiymati 16.08.2024 - 27.10.2026 oraligʻida

Quantum BioPharma Ltd. (QNTM) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Quantum BioPharma Ltd|QNTM - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Quantum BioPharma Limited|QNTM - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Quantum BioPharma|QNTM - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati quantumbiopharma.com|QNTM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Quantum BioPharma Ltd|QNTM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Quantum BioPharma Limited|QNTM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Quantum BioPharma Limited
Kompaniyaning dastlabki tahlili:Quantum BioPharma Ltd - QNTM
Quantum BioPharma Limited original mahsuloti

Quantum BioPharma Ltd (QNTM) global bozor uchun kengaytiriladigan terapevtik platformalarni ishlab chiqadi. Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlariga solishtirib, kelajakdagi o'sish uchun premiumni belgilaydi. Investorlar ushbu vositadan intellektual mulk uchun moddiy kapitalga nisbatan ortiqcha to'lovni baholashda foydalanadilar. Ushbu koeffitsientning barqarorligi patentlar baholash bo'yicha bozor konsensusini tasdiqlaydi. Narxning bukiya qiymatiga nisbati tendentsiyasidagi chegaralarning buzilishi fundamental kutishlarning o'zgarishidan dalolat beradi.

Asosiy raqobatchilar

HLN (Haleon plc) - Bozor qiymatining balans qiymatiga nisbati|KVUE (kenvue.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|HYFT (MindWalk Holdings Inc.) - Bozor qiymatining balans qiymatiga nisbati|ABVC - Bozor qiymatining xususiy kapitalga nisbati|Cumberland Pharma - Kapitallashuvning sof aktivlarga nisbati|FGEN - Bozor kapitallashuvining balans qiymatiga nisbati|TELO: Bozor kapitallashuvining balans qiymatiga nisbati|RANI (Rani Therapeutics Holdings, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corp. (SNYR)|Kapitallashuvning balans qiymatiga nisbati Rallybio Corp. (RLYB)|Kapitallashuvning sof aktivlarga nisbati Lexaria Bioscience|Bozor kapitallashuvining balans qiymatiga multiplikatori Pulmatrix Corporation PULM|Kapitallashuvning sof aktivlarga nisbati PTHL (Pheton Holdings)|Aptorum Group Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|LYRA: Bozor qiymatining balans qiymatiga nisbati|impactbiomedinc.com (IBO) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati tnfpharma.com TNFA|cbdMD (YCBD) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PainReform Ltd.|Bozor qiymatining balans qiymatiga nisbati Auris Medical|LIPO (Lipella Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OPTN (OptiNose Inc)|PIRS: Bozor qiymatining balans qiymatiga nisbati|Procaps Group Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals|QLI - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ACELYRIN SLRN|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor qiymati